Cargando…
Anti-tumor effect of AZD8055 against bladder cancer and bladder cancer-associated macrophages
The increased activity of the mTOR pathway in bladder cancer has been extensively studied, but no satisfactory mTOR inhibitor has been found in bladder cancer. The role of AZD8055, a second-generation mTOR inhibitor, has not been reported in bladder cancer. Herein, we investigated the effects of AZD...
Autores principales: | Hu, Weimin, Zhang, Yunlong, Ning, Jinzhuo, Li, Ming, Tang, Yuqi, Li, Linzhi, Cheng, Fan, Yu, Weimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020012/ https://www.ncbi.nlm.nih.gov/pubmed/36938467 http://dx.doi.org/10.1016/j.heliyon.2023.e14272 |
Ejemplares similares
-
Corrigendum to “Anti-tumor effect of AZD8055 against bladder cancer and bladder cancer-associated macrophages” [Heliyon 9(3) (March 2023) e14272]
por: Hu, Weimin, et al.
Publicado: (2023) -
MTHFD2 promotes PD‐L1 expression via activation of the JAK/STAT signalling pathway in bladder cancer
por: Li, Linzhi, et al.
Publicado: (2023) -
SQLE Knockdown inhibits bladder cancer progression by regulating the PTEN/AKT/GSK3β signaling pathway through P53
por: Zou, Fan, et al.
Publicado: (2023) -
The mTOR inhibitor AZD8055 inhibits proliferation and glycolysis in cervical cancer cells
por: LI, SHAORU, et al.
Publicado: (2013) -
In Vitro and In Vivo Interactions of TOR Inhibitor AZD8055 and Azoles against Pathogenic Fungi
por: Sun, Yi, et al.
Publicado: (2022)